Counterpoint Quantitative Equity Etf Performance
| CPAI Etf | USD 40.46 0.29 0.71% |
The etf shows a Beta (market volatility) of 1.19, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Counterpoint Quantitative will likely underperform.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Counterpoint Quantitative Equity are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, Counterpoint Quantitative is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders. ...more
1 | Counterpoint Quantitative Equity ETF Announces Annual Dividend of 0.36 | 12/12/2025 |
Counterpoint | Build AI portfolio with Counterpoint Etf |
Counterpoint Quantitative Relative Risk vs. Return Landscape
If you would invest 3,940 in Counterpoint Quantitative Equity on October 1, 2025 and sell it today you would earn a total of 106.00 from holding Counterpoint Quantitative Equity or generate 2.69% return on investment over 90 days. Counterpoint Quantitative Equity is currently generating 0.0502% in daily expected returns and assumes 1.2211% risk (volatility on return distribution) over the 90 days horizon. In different words, 10% of etfs are less volatile than Counterpoint, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Counterpoint Quantitative Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Counterpoint Quantitative's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Counterpoint Quantitative Equity, and traders can use it to determine the average amount a Counterpoint Quantitative's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0411
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | CPAI | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Counterpoint Quantitative is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Counterpoint Quantitative by adding it to a well-diversified portfolio.
Counterpoint Quantitative Fundamentals Growth
Counterpoint Etf prices reflect investors' perceptions of the future prospects and financial health of Counterpoint Quantitative, and Counterpoint Quantitative fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Counterpoint Etf performance.
| Return On Asset | -13.96 | |||
| Current Valuation | 855.13 K | |||
| Shares Outstanding | 121.81 M | |||
| Cash And Equivalents | 5.29 K | |||
| Total Debt | 115.25 K | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (72.58 K) | |||
| Total Asset | 27.76 K | |||
| Retained Earnings | (7.49 M) | |||
| Current Asset | 20 K | |||
| Current Liabilities | 2.34 M | |||
About Counterpoint Quantitative Performance
By evaluating Counterpoint Quantitative's fundamental ratios, stakeholders can gain valuable insights into Counterpoint Quantitative's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Counterpoint Quantitative has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Counterpoint Quantitative has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Champion Pain Care Corporation operates as a pain management company in the United States. Champion Pain Care Corporation was incorporated in 2009 and is based in New York, New York. CHAMPION PAIN operates under Medical Care Facilities classification in the United States and is traded on PNK Exchange.| Net Loss for the year was (5.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Counterpoint Quantitative Equity currently holds about 5.29 K in cash with (72.58 K) of positive cash flow from operations. | |
| Roughly 65.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: Counterpoint Quantitative Equity ETF Announces Annual Dividend of 0.36 | |
| The fund holds all of the assets under management (AUM) in different types of exotic instruments |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Counterpoint Quantitative Equity. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
The market value of Counterpoint Quantitative is measured differently than its book value, which is the value of Counterpoint that is recorded on the company's balance sheet. Investors also form their own opinion of Counterpoint Quantitative's value that differs from its market value or its book value, called intrinsic value, which is Counterpoint Quantitative's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Counterpoint Quantitative's market value can be influenced by many factors that don't directly affect Counterpoint Quantitative's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Counterpoint Quantitative's value and its price as these two are different measures arrived at by different means. Investors typically determine if Counterpoint Quantitative is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Counterpoint Quantitative's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.